Detection of neutralizing antibodies against multiple SARS-CoV-2 strains in dried blood spots using cell-free PCR

[1]  R. Andino,et al.  Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants , 2022, Cell.

[2]  M. Nussenzweig,et al.  High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape , 2021, Nature.

[3]  A. Huppert,et al.  BNT162b2 vaccine booster dose protection: A nationwide study from Israel , 2021, medRxiv.

[4]  G. Pantaleo,et al.  A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma , 2021, Science Translational Medicine.

[5]  Patrick W. Johnson,et al.  SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods , 2021, Journal of clinical microbiology.

[6]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[7]  L. Piemonti,et al.  Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival , 2021, Nature Communications.

[8]  R. Ahmed,et al.  Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination. , 2021, JAMA.

[9]  R. D’Aquila,et al.  A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples , 2021, Scientific Reports.

[10]  Peter V. Robinson,et al.  A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots , 2020, Scientific Reports.

[11]  M. Battegay,et al.  Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study , 2020, Blood.

[12]  G. Lozanski,et al.  Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors , 2020, JCI insight.

[13]  M. Chen,et al.  A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction , 2020, Nature Biotechnology.

[14]  Gregory M. Goldgof,et al.  SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area , 2020, medRxiv.

[15]  Y. Yazdanpanah,et al.  Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.

[16]  Y. Wen,et al.  Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.

[17]  Yan Peng,et al.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.

[18]  Lei Liu,et al.  Potent human neutralizing antibodies elicited by SARS-CoV-2 infection , 2020, bioRxiv.

[19]  Arturo Casadevall,et al.  The convalescent sera option for containing COVID-19. , 2020, The Journal of clinical investigation.

[20]  Samantha E. Zak,et al.  Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States , 2020, Transfusion.

[21]  Le Chang,et al.  Coronavirus Disease 2019: Coronaviruses and Blood Safety , 2020, Transfusion Medicine Reviews.

[22]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[23]  W. Ko,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.

[24]  J. Nie,et al.  Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.

[25]  Jonathan E. Schmitz,et al.  The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges 1 , 2020 .

[26]  Robert J. Fischer,et al.  Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape , 2018, Journal of Virology.

[27]  C. Bertozzi,et al.  Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis , 2018, Proceedings of the National Academy of Sciences.

[28]  C. Bertozzi,et al.  Isotype-specific agglutination-PCR (ISAP): A sensitive and multiplex method for measuring allergen-specific IgE. , 2017, The Journal of allergy and clinical immunology.

[29]  J. Dye,et al.  Apheresis for collection of Ebola convalescent plasma in Liberia , 2017, Journal of clinical apheresis.

[30]  Matteo Ricchi,et al.  A Basic Guide to Real Time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything , 2017, Front. Microbiol..

[31]  Carolyn R. Bertozzi,et al.  Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP) , 2016, ACS central science.

[32]  T. Hervig,et al.  Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers , 2008, Transfusion.

[33]  Newal K. Agnihotri.  Current Issues and Challenges , 2004 .

[34]  U. Landegren,et al.  Protein detection using proximity-dependent DNA ligation assays , 2002, Nature Biotechnology.